5CDB
Structure of the complex of a bimolecular human telomeric DNA with a 13-diphenylalkyl Berberine derivative
Summary for 5CDB
Entry DOI | 10.2210/pdb5cdb/pdb |
Descriptor | human telomeric DNA, POTASSIUM ION, 13-diphenylalkyl Berberine, ... (4 entities in total) |
Functional Keywords | drug-dna complex, g-quadruplex, dna |
Biological source | Homo sapiens |
Total number of polymer chains | 2 |
Total formula weight | 8169.78 |
Authors | Ferraroni, M.,Bazzicalupi, C.,Gratteri, P.,Papi, F. (deposition date: 2015-07-03, release date: 2016-07-20, Last modification date: 2024-01-10) |
Primary citation | Ferraroni, M.,Bazzicalupi, C.,Papi, F.,Fiorillo, G.,Guaman-Ortiz, L.M.,Nocentini, A.,Scovassi, A.I.,Lombardi, P.,Gratteri, P. Solution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexes. Chem Asian J, 11:1107-1115, 2016 Cited by PubMed Abstract: The interaction between 13-phenylalkyl and 13-diphenylalkyl berberine derivatives (NAX) and human telomeric DNA G4 structures has been investigated by both spectroscopic and crystallographic methods. NAX042 and NAX053 are the best compounds improving the performance of the natural precursor berberine. This finding is in agreement with the X-ray diffraction result for the NAX053-Tel12 adduct, showing the ligand which interacts via π-stacking, sandwiched at the interface of two symmetry-related quadruplex units, with its benzhydryl group contributing to the overall stability of the adduct by means of additional π-stacking interactions with the DNA residues. The berberine derivatives were also investigated for their cytotoxic activity towards a panel of human cancer cell lines. Compounds NAX042 and NAX053 affect the viability of cancer cell lines in a dose-dependent manner. PubMed: 26865223DOI: 10.1002/asia.201600116 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report
